Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Capital Leases (2016 - 2018)

Amphastar Pharmaceuticals (AMPH) has 6 years of Capital Leases data on record, last reported at $1.1 million in Q4 2018.

  • For Q4 2018, Capital Leases fell 22.25% year-over-year to $1.1 million; the TTM value through Dec 2018 reached $1.1 million, down 22.25%, while the annual FY2018 figure was $1.1 million, 22.25% down from the prior year.
  • Capital Leases reached $1.1 million in Q4 2018 per AMPH's latest filing, down from $1.1 million in the prior quarter.
  • Across five years, Capital Leases topped out at $1.9 million in Q2 2016 and bottomed at $802000.0 in Q4 2015.
  • Average Capital Leases over 5 years is $1.3 million, with a median of $1.2 million recorded in 2018.
  • Peak YoY movement for Capital Leases: surged 101.25% in 2016, then fell 22.25% in 2018.
  • A 5-year view of Capital Leases shows it stood at $1.0 million in 2014, then fell by 21.53% to $802000.0 in 2015, then skyrocketed by 101.25% to $1.6 million in 2016, then decreased by 15.92% to $1.4 million in 2017, then dropped by 22.25% to $1.1 million in 2018.
  • Per Business Quant database, its latest 3 readings for Capital Leases were $1.1 million in Q4 2018, $1.1 million in Q3 2018, and $1.2 million in Q2 2018.